Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ciclosporine/trehalose - Huons

Next Previous
X
Search
Drug Profile

Ciclosporine/trehalose - Huons

Alternative Names: Cyclosporine/trehalose; HU-007; HU-00701; trehalose/Ciclosporine; trehalose/Cyclosporine

Latest Information Update: 20 May 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Huons
  • Class Ciclosporins; Disaccharides; Eye disorder therapies; Glucans; Small molecules
  • Mechanism of Action Autophagy stimulants; Calcineurin inhibitors; Enzyme inhibitors; Immunosuppressants; Mitochondrial permeability transition pore inhibitors; P-glycoprotein inhibitors; Protein aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Dry eyes

Most Recent Events

  • 14 Feb 2024 Huons completes a phase III trial in Dry eyes in South Korea (Opthalmic) (NCT05743764)
  • 01 Mar 2023 Huons initiates enrolment in a phase III trial in Dry eyes in South Korea (Opthalmic) (NCT05743764)
  • 24 Feb 2023 Huons plans a phase III trial in Dry eyes in March 2023 (Opthalmic) (NCT05743764)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top